$ARGS ARGOS THERAPEUTICS INC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARGOS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARGOS THERAPEUTICS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ARGOS THERAPEUTICS INC for free.
IRS Number: 562110007
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ARGS
Company Address: 4233 TECHNOLOGY DR DURHAM 27704
Phone number: 9192876300
Former name: MERIX BIOSCIENCE INC, date of change: 2000-02-07
Market Capitalization: $208.29M
Prev close: $4.85
Average Daily Volume: 172,668
Days Low: $4.62
Year Low: $3.45
Year High: $13.97
ARGOS THERAPEUTICS INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 25 2018 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Sell | D | 0.00 | 67,887 | 0 | 25,450 | 93.3 K to 25.5 K (-72.73 %) |
| Apr 25 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Sell | D | 0.00 | 22,629 | 0 | 9,697 | 32.3 K to 9.7 K (-70.00 %) |
| Apr 25 2018 | ARGS | ARGOS THERAPEUTICS ... | Harrelson Lori R. | Vice President of F ... | Sell | D | 0.00 | 22,629 | 0 | 11,776 | 34.4 K to 11.8 K (-65.77 %) |
| Apr 25 2018 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO and Vice Presid ... | Sell | D | 0.00 | 27,150 | 0 | 20,056 | 47.2 K to 20.1 K (-57.51 %) |
| Apr 02 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Grant | A | 0.00 | 22,629 | 0 | 32,326 | 9.7 K to 32.3 K (+233.36 %) |
| Apr 02 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Grant | A | 0.00 | 22,629 | 0 | 32,326 | 9.7 K to 32.3 K (+233.36 %) |
| Mar 30 2018 | ARGS | ARGOS THERAPEUTICS ... | Harrelson Lori R. | Vice President of F ... | Grant | A | 0.00 | 22,629 | 0 | 34,405 | 11.8 K to 34.4 K (+192.16 %) |
| Mar 30 2018 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO and Vice Presid ... | Grant | A | 0.00 | 27,150 | 0 | 47,206 | 20.1 K to 47.2 K (+135.37 %) |
| Mar 30 2018 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Grant | A | 0.00 | 67,887 | 0 | 93,337 | 25.5 K to 93.3 K (+266.75 %) |
| Jan 12 2018 | ARGS | ARGOS THERAPEUTICS ... | Harrelson Lori R. | Vice President of F ... | Sell | S | 0.16 | 64,329 | 10,595 | 230,981 | 295.3 K to 231 K (-21.78 %) |
| Jan 12 2018 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO and Vice Presid ... | Sell | S | 0.16 | 100,250 | 16,501 | 399,990 | 500.2 K to 400 K (-20.04 %) |
| Jan 12 2018 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | President, CEO | Sell | S | 0.16 | 124,987 | 20,573 | 510,046 | 635 K to 510 K (-19.68 %) |
| Jan 12 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Sell | S | 0.16 | 104,435 | 17,200 | 193,959 | 298.4 K to 194 K (-35.00 %) |
| Jan 05 2018 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | President, CEO | Sell | S | 0.16 | 114,702 | 18,719 | 635,033 | 749.7 K to 635 K (-15.30 %) |
| Jan 05 2018 | ARGS | ARGOS THERAPEUTICS ... | Katz Richard D | Vice President and ... | Sell | S | 0.16 | 101,228 | 16,541 | 298,394 | 399.6 K to 298.4 K (-25.33 %) |